Treatment of neuropsychiatric syndromes in multiple sclerosis.
about
Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.Relationship between psychosocial factors and onset of multiple sclerosis.Progressive multiple sclerosis and mood disorders.Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study.
P2860
Treatment of neuropsychiatric syndromes in multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@ast
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@en
type
label
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@ast
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@en
prefLabel
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@ast
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@en
P2860
P356
P1476
Treatment of neuropsychiatric syndromes in multiple sclerosis.
@en
P2860
P304
P356
10.1586/14737175.5.3.413
P577
2005-05-01T00:00:00Z